Annual EBITDA:
$100.16M+$167.99M(+247.67%)Summary
- As of today, ACAD annual EBITDA is $100.16 million, with the most recent change of +$167.99 million (+247.67%) on December 31, 2024.
- During the last 3 years, ACAD annual EBITDA has risen by +$267.26 million (+159.94%).
- ACAD annual EBITDA is now at all-time high.
Performance
ACAD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$35.31M+$13.07M(+58.76%)Summary
- As of today, ACAD quarterly EBITDA is $35.31 million, with the most recent change of +$13.07 million (+58.76%) on June 30, 2025.
- Over the past year, ACAD quarterly EBITDA has increased by +$2.30 million (+6.97%).
- ACAD quarterly EBITDA is now -3.48% below its all-time high of $36.58 million, reached on December 31, 2023.
Performance
ACAD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$103.97M+$2.30M(+2.26%)Summary
- As of today, ACAD TTM EBITDA is $103.97 million, with the most recent change of +$2.30 million (+2.26%) on June 30, 2025.
- Over the past year, ACAD TTM EBITDA has increased by +$69.69 million (+203.34%).
- ACAD TTM EBITDA is now -16.52% below its all-time high of $124.54 million, reached on September 30, 2024.
Performance
ACAD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ACAD EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +247.7% | +7.0% | +203.3% |
| 3Y3 Years | +159.9% | +206.6% | +150.9% |
| 5Y5 Years | +141.1% | +181.6% | +138.1% |
ACAD EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +145.2% | -3.5% | +163.0% | -16.5% | +146.9% |
| 5Y | 5-Year | at high | +135.3% | -3.5% | +131.4% | -16.5% | +136.7% |
| All-Time | All-Time | at high | +134.6% | -3.5% | +131.4% | -16.5% | +133.7% |
ACAD EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $35.31M(+58.8%) | $103.97M(+2.3%) |
| Mar 2025 | - | $22.24M(+82.3%) | $101.67M(+1.5%) |
| Dec 2024 | $100.16M(+247.7%) | $12.20M(-64.3%) | $100.16M(-19.6%) |
| Sep 2024 | - | $34.21M(+3.7%) | $124.54M(+263.4%) |
| Jun 2024 | - | $33.01M(+59.2%) | $34.27M(+464.7%) |
| Mar 2024 | - | $20.74M(-43.3%) | $6.07M(+108.9%) |
| Dec 2023 | -$67.83M(+69.4%) | $36.58M(+165.3%) | -$67.83M(+54.8%) |
| Sep 2023 | - | -$56.05M(-1267.0%) | -$149.98M(-20.7%) |
| Jun 2023 | - | $4.80M(+109.0%) | -$124.29M(+23.4%) |
| Mar 2023 | - | -$53.16M(-16.6%) | -$162.23M(+26.8%) |
| Dec 2022 | -$221.57M(-32.6%) | -$45.57M(-50.1%) | -$221.57M(-0.7%) |
| Sep 2022 | - | -$30.36M(+8.4%) | -$220.12M(-7.9%) |
| Jun 2022 | - | -$33.14M(+70.5%) | -$204.07M(+4.5%) |
| Mar 2022 | - | -$112.50M(-155.0%) | -$213.72M(-27.9%) |
| Dec 2021 | -$167.09M(+41.1%) | -$44.12M(-208.2%) | -$167.09M(+11.7%) |
| Sep 2021 | - | -$14.32M(+66.5%) | -$189.30M(+27.2%) |
| Jun 2021 | - | -$42.78M(+35.1%) | -$260.17M(+0.2%) |
| Mar 2021 | - | -$65.88M(+0.7%) | -$260.68M(+8.1%) |
| Dec 2020 | -$283.65M(-16.4%) | -$66.32M(+22.1%) | -$283.65M(-3.9%) |
| Sep 2020 | - | -$85.19M(-96.8%) | -$273.09M(-17.4%) |
| Jun 2020 | - | -$43.29M(+51.3%) | -$232.67M(+5.3%) |
| Mar 2020 | - | -$88.85M(-59.3%) | -$245.78M(-0.8%) |
| Dec 2019 | -$243.78M(+0.3%) | -$55.76M(-24.6%) | -$243.78M(+4.2%) |
| Sep 2019 | - | -$44.77M(+20.6%) | -$254.51M(+5.8%) |
| Jun 2019 | - | -$56.40M(+35.1%) | -$270.26M(+2.5%) |
| Mar 2019 | - | -$86.85M(-30.6%) | -$277.23M(-13.4%) |
| Dec 2018 | -$244.44M(+15.6%) | -$66.49M(-9.9%) | -$244.44M(+1.1%) |
| Sep 2018 | - | -$60.52M(+4.5%) | -$247.25M(+1.8%) |
| Jun 2018 | - | -$63.37M(-17.2%) | -$251.68M(+1.6%) |
| Mar 2018 | - | -$54.06M(+22.0%) | -$255.67M(+11.7%) |
| Dec 2017 | -$289.70M(-6.9%) | -$69.31M(-6.7%) | -$289.70M(+2.8%) |
| Sep 2017 | - | -$64.95M(+3.6%) | -$297.99M(+2.2%) |
| Jun 2017 | - | -$67.36M(+23.5%) | -$304.83M(+1.3%) |
| Mar 2017 | - | -$88.08M(-13.5%) | -$308.94M(-14.0%) |
| Dec 2016 | -$270.99M(-65.3%) | -$77.60M(-8.1%) | -$270.99M(-13.5%) |
| Sep 2016 | - | -$71.79M(-0.4%) | -$238.82M(-16.0%) |
| Jun 2016 | - | -$71.47M(-42.6%) | -$205.91M(-18.6%) |
| Mar 2016 | - | -$50.12M(-10.3%) | -$173.66M(-5.9%) |
| Dec 2015 | -$163.97M(-76.3%) | -$45.44M(-16.9%) | -$163.97M(-11.5%) |
| Sep 2015 | - | -$38.88M(+0.9%) | -$147.02M(-10.5%) |
| Jun 2015 | - | -$39.22M(+3.0%) | -$133.07M(-15.2%) |
| Mar 2015 | - | -$40.43M(-41.9%) | -$115.54M(-24.2%) |
| Dec 2014 | -$93.02M(-143.4%) | -$28.49M(-14.3%) | -$93.02M(-21.4%) |
| Sep 2014 | - | -$24.93M(-15.0%) | -$76.66M(-22.6%) |
| Jun 2014 | - | -$21.68M(-21.0%) | -$62.52M(-25.1%) |
| Mar 2014 | - | -$17.91M(-47.8%) | -$49.98M(-30.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$38.22M(-83.9%) | -$12.13M(-12.3%) | -$38.22M(-16.2%) |
| Sep 2013 | - | -$10.79M(-18.0%) | -$32.89M(-34.2%) |
| Jun 2013 | - | -$9.14M(-48.7%) | -$24.50M(-17.9%) |
| Mar 2013 | - | -$6.15M(+9.5%) | -$20.79M(+0.4%) |
| Dec 2012 | -$20.78M(+7.9%) | -$6.80M(-182.4%) | -$20.86M(-7.8%) |
| Sep 2012 | - | -$2.41M(+55.7%) | -$19.35M(+12.1%) |
| Jun 2012 | - | -$5.43M(+12.9%) | -$22.01M(+4.8%) |
| Mar 2012 | - | -$6.23M(-17.9%) | -$23.13M(-2.5%) |
| Dec 2011 | -$22.57M(-243.7%) | -$5.28M(-4.4%) | -$22.57M(-287.4%) |
| Sep 2011 | - | -$5.06M(+22.7%) | $12.04M(-7.1%) |
| Jun 2011 | - | -$6.55M(-15.4%) | $12.96M(-15.6%) |
| Mar 2011 | - | -$5.67M(-119.3%) | $15.35M(-2.2%) |
| Dec 2010 | $15.70M(+135.4%) | $29.32M(+808.1%) | $15.70M(+171.8%) |
| Sep 2010 | - | -$4.14M(+0.4%) | -$21.88M(+16.8%) |
| Jun 2010 | - | -$4.16M(+21.9%) | -$26.30M(+24.3%) |
| Mar 2010 | - | -$5.32M(+35.6%) | -$34.74M(+21.7%) |
| Dec 2009 | -$44.36M(+32.7%) | -$8.26M(+3.4%) | -$44.36M(+11.8%) |
| Sep 2009 | - | -$8.55M(+32.1%) | -$50.31M(+11.8%) |
| Jun 2009 | - | -$12.60M(+15.7%) | -$57.06M(+9.4%) |
| Mar 2009 | - | -$14.94M(-5.2%) | -$62.99M(+5.0%) |
| Dec 2008 | -$65.94M(-6.5%) | -$14.21M(+7.2%) | -$66.33M(+5.4%) |
| Sep 2008 | - | -$15.31M(+17.4%) | -$70.08M(+3.6%) |
| Jun 2008 | - | -$18.53M(-1.4%) | -$72.66M(-8.9%) |
| Mar 2008 | - | -$18.28M(-1.8%) | -$66.73M(-8.5%) |
| Dec 2007 | -$61.89M(-26.2%) | -$17.96M(-0.4%) | -$61.51M(-7.7%) |
| Sep 2007 | - | -$17.89M(-42.0%) | -$57.09M(-10.8%) |
| Jun 2007 | - | -$12.60M(+3.4%) | -$51.52M(+0.1%) |
| Mar 2007 | - | -$13.05M(+3.7%) | -$51.59M(-6.5%) |
| Dec 2006 | -$49.05M(-41.0%) | -$13.55M(-10.0%) | -$48.45M(-6.7%) |
| Sep 2006 | - | -$12.32M(+2.8%) | -$45.39M(+0.6%) |
| Jun 2006 | - | -$12.67M(-27.8%) | -$45.67M(-16.5%) |
| Mar 2006 | - | -$9.91M(+5.5%) | -$39.20M(-12.7%) |
| Dec 2005 | -$34.78M(-40.3%) | -$10.49M(+16.7%) | -$34.78M(-10.8%) |
| Sep 2005 | - | -$12.59M(-103.1%) | -$31.39M(-26.5%) |
| Jun 2005 | - | -$6.20M(-12.9%) | -$24.81M(-2.6%) |
| Mar 2005 | - | -$5.49M(+22.6%) | -$24.19M(+2.4%) |
| Dec 2004 | -$24.79M(-100.0%) | -$7.10M(-18.0%) | -$24.79M(+32.9%) |
| Sep 2004 | - | -$6.02M(-7.9%) | -$36.97M(-27.0%) |
| Jun 2004 | - | -$5.58M(+8.5%) | -$29.10M(-13.8%) |
| Mar 2004 | - | -$6.10M(+68.4%) | -$25.57M(-17.5%) |
| Dec 2003 | -$12.40M(-10.5%) | -$19.27M(-1144.9%) | -$21.75M(-777.5%) |
| Sep 2003 | - | $1.84M(+190.3%) | -$2.48M(+42.7%) |
| Jun 2003 | - | -$2.04M(+10.5%) | -$4.32M(-89.5%) |
| Mar 2003 | - | -$2.28M | -$2.28M |
| Dec 2002 | -$11.22M(+26.5%) | - | - |
| Dec 2001 | -$15.28M(-35.6%) | - | - |
| Dec 2000 | -$11.27M | - | - |
FAQ
- What is ACADIA Pharmaceuticals Inc. annual EBITDA?
- What is the all-time high annual EBITDA for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. annual EBITDA year-on-year change?
- What is ACADIA Pharmaceuticals Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. quarterly EBITDA year-on-year change?
- What is ACADIA Pharmaceuticals Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. TTM EBITDA year-on-year change?
What is ACADIA Pharmaceuticals Inc. annual EBITDA?
The current annual EBITDA of ACAD is $100.16M
What is the all-time high annual EBITDA for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high annual EBITDA is $100.16M
What is ACADIA Pharmaceuticals Inc. annual EBITDA year-on-year change?
Over the past year, ACAD annual EBITDA has changed by +$167.99M (+247.67%)
What is ACADIA Pharmaceuticals Inc. quarterly EBITDA?
The current quarterly EBITDA of ACAD is $35.31M
What is the all-time high quarterly EBITDA for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high quarterly EBITDA is $36.58M
What is ACADIA Pharmaceuticals Inc. quarterly EBITDA year-on-year change?
Over the past year, ACAD quarterly EBITDA has changed by +$2.30M (+6.97%)
What is ACADIA Pharmaceuticals Inc. TTM EBITDA?
The current TTM EBITDA of ACAD is $103.97M
What is the all-time high TTM EBITDA for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high TTM EBITDA is $124.54M
What is ACADIA Pharmaceuticals Inc. TTM EBITDA year-on-year change?
Over the past year, ACAD TTM EBITDA has changed by +$69.69M (+203.34%)